Skip to content
DataLookout
Menu

VOYAGER CENCT07696182

Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment increased: 150 → 300 participants
    • Eligibility criteria expanded, about 7 words
    • Trial sites expanded: 0 → 36 locations
    • Interventions modified
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Composite of all-cause mortality or all strokes at 12 months post index
Timeframe: 12 months post index

Arms and interventions

Encantor TAVI SystemExperimental

The Encantor System is intended to treat patients with symptomatic severe aortic stenosis via transcatheter aortic valve implantation (TAVI)

Devices: Transcatheter valve replacement therapy

Sites

36 sites in 8 countries

Germany 11, Australia 7, France 6, Italy 5, Spain 3, Sweden 2, Norway 1, Portugal 1